IgM de-myelinating neuropathy as a complication of MGUS and WM
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2024-11-04
Просмотров: 1275
Описание:
Shirley D'Sa, MD, FRCP, FRCPath, University College London, London, United Kingdom, discusses IgM de-myelinating neuropathy as a complication of monoclonal gammopathy of undetermined significance (MGUS) and Waldenström's macroglobulinemia (WM). She notes that rituximab is commonly used to treat this complication, with alternative options like BTK inhibitors available if rituximab proves ineffective. This interview took place at the 12th International Workshop on Waldenström's Macroglobulinemia (IWWM-12) in Prague, Czech Republic.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
